Antihistamine Market Outlook for 2023 to 2033

The global antihistamine product market was valued at US$ 263.9 billion in 2022. The market is expected to expand at a CAGR of 8.6% and reach a valuation of ~US$ 647.7 billion by 2033.

Data Points Market Insights
Antihistamine Market Value, 2022 US$ 263.9 billion
Antihistamine Market Value, 2023 US$ 284.2 billion
Antihistamine Market Value, 2033 US$ 647.7 billion
CAGR (2023 to 2033) 8.6%
Market Share of Top 5 Countries 50.5%
Key Market Players GlaxoSmithKline PLC., Sanofi Consumer Healthcare, Himalaya Wellness Company, Sun Pharmaceutical Industries, Inc., Bayer AG, Novartis AG, Cadila Pharmaceuticals, Bausch Health Companies Inc., Alcon Vision LLC., Merck & Co., Dr. Reddy’s Laboratories, Ltd., Viatris Inc., Somerset Pharma, LLC, F. Hoffmann- La Roche Ltd., Akorn Operating Company LLC, Teva Pharmaceutical Industries Ltd., Speer laboratories, Glenmark Pharmaceuticals Limited, TerSera Therapeutics LLC, Pfizer Inc., Morepen Laboratories Limited, Johnson & Johnson Sevices Inc., Pharmaceutical Specialties Inc., Proctor & Gamble

The antihistamine market has observed significant growth over the last decade. The increasing prevalence of allergies and allergic reactions across the globe has expanded the growth of the antihistamine market. Antihistamine drugs are used to treat a variety of allergies and allergic reactions, as it is an anti-allergic medication. The body acts on certain histamine receptors and releases histamine throughout an allergic reaction. Antihistamine can also treat pruritus-related conditions such as atopic dermatitis, insect bites, and other conditions. Moreover, H-1 and H-2 types of antihistamine are used to treat other conditions such as insomnia, motion sickness, anxiety and heartburn, gastric ulcers, and others, respectively.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Performance of Antihistamine Market from 2017 to 2022 Vs Market Outlook for 2023 to 2033

The market value for antihistamines was approximately 1.3% of the overall global allergy treatment market worth ~US$ 19,070.0 billion in 2022.

Historical Antihistamine Market Value (2022) US$ 263.9 billion
Historical CAGR (2017 to 2022) 5.9%

The sale of antihistamines expanded at a CAGR of 5.9% from 2017 to 2022. The demand for antihistamine products will keep up strong in the years ahead. The preference for antihistamine drugs for treatment procedures is growing as the accessibility of these drugs is highly convenient through retail pharmacies, hospital pharmacies, and online pharmacies. This is one of the factors influencing the production growth of antihistamines. Numerous manufacturers are utilizing different antihistamine dosage forms to enhance their market share.

Allergic reactions caused on the skin are distinguished by red, peeling, dry, swollen surface, itch, and rash. The most common triggering factor for allergies is the overreaction of histamine in the body; this is when antihistamines come into action. Antihistamines assist in reducing inflammation, which usually alleviates the pain. Apart from that, skin conditions such as allergic rhinitis can occur due to prolonged and repeated exposure to dust mites, molds, or pet dander. It can further lead to symptoms such as nasal congestion and irritation in the nose, throat, and eyes, increasing the growth of the antihistamine market.

Medical professionals prescribe antihistamines to relieve symptoms of insomnia as well. Due to the current environment and lifestyle, such as unstable working shifts, smoking, varied sleeping patterns and others, the antihistamine market has witnessed growth in conditions such as insomnia, which is the most common issue among the general population today. According to an article published by the American Journal of Managed Care in 2020, around 30% to 40% of the U.S adult population develop symptoms of insomnia per year. The inability to fall asleep or stay asleep can have a major influence on productivity and mood. It can be a symptom or a cause of other underlying medical disorders. Easily available over-the-counter drugs such as diphenhydramine can assist in sleeping aids. An antihistamine is not a first-line treatment for insomnia but first-generation antihistamine blocks H-1 histamine receptors, which can cause sedation and make the patients drowsy. These factors can be favorable for the antihistamine market.

Thus, owing to the aforementioned factors, the global market is expected to grow at a CAGR of 8.6% during the forecast period from 2023 to 2033.

Key Opportunities in the Antihistamine Market

The growth will be driven by the increasing concerns regarding the prevalence of allergic reactions and other conditions such as urticaria and anxiety across the globe. Further, the market opportunistic outlook is owing to the increasing investments in research and development, due to which drug approvals are rising and new products concerning antihistamine drugs are being launched, which is expanding the market.

For instance, in May 2022, Glenmark Pharmaceuticals launched a nasal spray in India named Ryaltris-AZ. Ryaltris-AZ was introduced as the first-line treatment for allergic rhinitis with a mixture of intranasal antihistamines and corticosteroids.

Moreover, a number of manufacturers are expanding their line of medications by providing antihistamine drugs in multiple routes of administration, increasing the range of antihistamine-related products in the market. Hence, in the forthcoming years, the antihistamine market is expected to dispense lucrative growth opportunities.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Restraints in the Antihistamine Market

Sometimes, due to a lack of awareness among the rural population in some developing countries, it becomes difficult to cope with allergies and other conditions. It is because of negligence and inability to seek medical help. This is a crucial factor hampering the growth of the market.

Antihistamine blocks the process of histamine, but at times, there are a few side effects that can be caused due to antihistamines. These side effects include drowsiness, dry mouth, dry eyes, sore throat, and others. This factor acts as a barrier and affects the growth of the market in a negative manner.

Country-wise Insights

Countries CAGR (2023 to 2033)
United States 8.9%
China 8.6%
United Kingdom 8.0%
Germany 8.2%
India 7.8%

Prevalence of Allergies in the United States Drive Sales of Antihistamines

The United States dominates the North American region, with a total market share of about 85.4% in 2022. The market is expected to grow at a CAGR of 8.9% through 2033.

According to the Centers for Disease Control and Prevention, more than 60 million people per year in the United States suffer from hay fever. It was also reported that seven out of ten patients in 2020 were suffering from hay fever along with allergic conjunctivitis that causes red, watery, and itchy eyes. The prevalence of allergies in the U.S. is driving the market. There are numerous antihistamine medications that provide relief from such inflammation symptoms. These are the prime drivers for the market within the country.

Rising Demand For Antihistamines in China Due to Allergies Among Children

China dominates the East Asian region with a total market share of about 51.2%. It is estimated to grow at a CAGR of 8.6% throughout the forecast period.

Allergic rhinitis is becoming a major concern in terms of health and economy in China. Children in China are more prone to such disorders due to allergens like house dust mites. As the prevalence of allergies and allergic reactions is rising, the demand for antihistamines is increasing, boosting market growth.

Increasing Prevalence of Allergic Conjunctivitis in India

India is set to exhibit a CAGR growth rate of nearly 7.8% during the forecast period. Due to the increasing prevalence of allergic conjunctivitis in the general population of India, the consumption of the antihistamines for the treatment is increasing, contributing to the growth of the Indian market.

Allergy-based disorders in India are becoming a matter of concern due to factors like the illiteracy among the rural population and paucity of allergy specialists.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

H-1 Blockers Dominate the Market by Product

Top Product H-1 blockers
CAGR (2023 to 2033) 8.9%

H-1 blockers are expected to present high growth at a CAGR of 8.9% over the forecast period, with a market share of about 55.9%. H-1 antihistamines can alleviate the pain caused by allergic conjunctivitis, skin rashes and hypersensitivity toward certain drugs.

Sales of Antihistamines through Over-the-Counter

Top Type Over-the-counter
CAGR (2023 to 2033) 9.0%

Over-the-counter antihistamines are dominating the market with a share of 51.3% in 2022. This segment is expected to present high growth at a CAGR of 9.0% by the end of the forecast period. Antihistamine drugs are easily available through over-the-counter means. Therefore, this segment is considered to be dominant in the type category.

Tablets are Highly Preferred Dosage Form

Top Dosage Tablets
CAGR (2023 to 2033) 9.7%

Tablets hold a market share of 35.0% in 2022 and are expected to display gradual growth over the forecast period, with a CAGR of 9.7%. Tablets are one the most convenient and economical dosage forms of antihistamines.

Oral Route of Drug Administration Dominates the Market

Top Route of Administration Oral
CAGR (2023 to 2033) 8.0%

The oral route of administration is dominating the market and is expected to grow at a CAGR of 8.0% over the forecast period, with a market share of about 48.7% in the global market in 2031. Oral medications are quite advantageous as compared to parental and topical medications. These advantages include patient preference, the convenience of drug administration, and cost-effectiveness.

Hospital Pharmacies Facilitate Higher Sales of Antihistamine Drugs

Top Distribution Channel Hospital pharmacies
CAGR (2023 to 2033) 9.1%

Hospital pharmacies hold a prominent market share value of 42.9% during the year 2022 with a CAGR of 9.1%. The increasing number of hospital pharmacies is a factor contributing to the prominent share of hospital pharmacies in the distribution channel category.

Competitive Landscape and Recent Developments

The market is a highly fragmented market with numerous key players. To meet consumer demands and strengthen their presence worldwide, these companies are executing a new range of products and regulatory approvals. Few of the key developmental strategies of market players are given below:

  • In June 2020, Cadila Pharmaceuticals announced the launch of Bilastin syrup and tablets in India. Bilastin is an anti-allergic drug used for the treatment of allergic rhinitis.
  • In December 2022, Morepen Laboratories Limited announced the U.S. FDA approval of fexofenadine hydrochloride. It is an anti-allergy drug used for the treatment of symptoms due to allergies and hay fever. It was launched under the brand ‘Allerga’

Report Scope as per Market Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ billion for Value
Key Regions Covered North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, France, Italy, UK, Spain, Russia BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Market Segments Covered Product, Type, Dosage Forms, Route of Administration, Indication, Distribution Channel and Region
Key Companies Profiled GlaxoSmithKline PLC.; Sanofi Consumer Healthcare; Himalaya Wellness Company; Sun Pharmaceutical Industries, Inc.; Bayer AG; Novartis AG; Cadila Pharmaceuticals; Bausch Health Companies Inc.; Alcon Vision LLC.; Merck & Co.; Dr. Reddy’s Laboratories, Ltd.; Viatris Inc.; Somerset Pharma, LLC; F. Hoffmann- La Roche Ltd.; Akorn Operating Company LLC; Teva Pharmaceutical Industries Ltd.; Speer laboratories; Glenmark Pharmaceuticals Limited; TerSera Therapeutics LLC; Pfizer Inc.; Morepen Laboratories Limited; Johnson & Johnson Services Inc.; Pharmaceutical Specialties Inc.; Proctor & Gamble
Pricing Available upon Request

Key Market Segments Covered in Market Industry Research

By Product:

  • H-1 Blockers
  • H-2 Blockers

By Type:

  • Prescription-based
  • Over-the-counter

By Dosage Forms:

  • Tablets
  • Capsules
  • Liquids
  • Other

By Route of Administration:

  • Oral
  • Parenteral
  • Topical

By Indication:

  • Allergies
  • Urticaria
  • Dermatitis
  • Other

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How Much was the Value of the Antihistamine Market in 2022?

The global antihistamine market is worth US$ 263.9 billion in 2022.

What is the Sales Forecast for Antihistamines through 2033?

The antihistamine market is expected to reach US$ 647.7 billion by 2033, growing at a CAGR of 8.6% over the forecast period.

What are the Trends Driving the Global Antihistamine Market?

Increased efficacy of antihistamines with respect to relieving symptoms and allergic reactions across the globe.

Which Region has the Prominent Share in the Global Antihistamine Market?

North America dominated the global antihistamine market accounting for a prominent market share of 34.6%.

How is the Market Expected to Grow in India?

The market in India is likely to grow with a CAGR of 7.8% over the forecast period.

Which are the Top Five Countries Driving the Demand for Antihistamines?

The United States, China, the United Kingdom, Germany, and India are the top five countries, which are expected to drive demand for antihistamines.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Product Innovation / Development Trends
4. Value Added Insights
    4.1. Product Adoption / Usage Analysis
    4.2. Product USPs / Features
    4.3. PESTLE Analysis
    4.4. Porter Analysis
    4.5. Regulatory Scenario
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global GDP Growth Outlook
        5.1.2. Global Healthcare Expenditure Outlook
        5.1.3. Global Allergy Treatment Market Outlook
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Historic Growth of the Top Companies
        5.2.2. Rising Prevalence of Allergies and Allergic Reactions
        5.2.3. Mergers and Acquisitions
        5.2.4. Strategic Collaborations
        5.2.5. Adoption Rate
        5.2.6. Product and Stock Availability
    5.3. Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Billion) Analysis 2017 to 2022 and Forecast, 2023 to 2033
    6.1. Historical Market Value (US$ Billion) Analysis, 2017 to 2022
    6.2. Current and Future Market Value (US$ Billion) Projections, 2023 to 2033
        6.2.1. Y-o-Y Growth Trend Analysis
        6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product 
    7.1. Introduction / Key Findings
    7.2. Historical Market Size (US$ Billion) Analysis By Product, 2017 to 2022
    7.3. Current and Future Market Size (US$ Billion) and Analysis and Forecast By Product, 2023 to 2033
        7.3.1. H-1 Blockers
        7.3.2. H-2 Blockers
    7.4. Market Attractiveness Analysis By Product
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Type 
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Billion) Analysis By Type, 2017 to 2022
    8.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Type, 2023 to 2033
        8.3.1. Prescription-based
        8.3.2. Over-the-counter
    8.4. Market Attractiveness Analysis By Type
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Forms
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Billion) Analysis By Dosage Forms, 2017 to 2022
    9.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Dosage Forms, 2023 to 2033
        9.3.1. Tablets
        9.3.2. Capsules
        9.3.3. Liquids
        9.3.4. Other
    9.4. Market Attractiveness Analysis By Dosage Forms
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Billion) Analysis By Route of Administration, 2017 to 2022
    10.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Route of Administration, 2023 to 2033
        10.3.1. Oral
        10.3.2. Parenteral
        10.3.3. Topical
    10.4. Market Attractiveness Analysis By Route of Administration
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication 
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ Billion) Analysis By Indication, 2017 to 2022
    11.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Indication, 2023 to 2033
        11.3.1. Allergies
        11.3.2. Urticaria
        11.3.3. Dermatitis
        11.3.4. Others
    11.4. Market Attractiveness Analysis By Indication
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
    12.1. Introduction / Key Findings
    12.2. Historical Market Size (US$ Billion) Analysis By Distribution Channel, 2017 to 2022
    12.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Distribution Channel, 2023 to 2033
        12.3.1. Hospital Pharmacies
        12.3.2. Retail Pharmacies
        12.3.3. Drug Stores
        12.3.4. Online Pharmacies
    12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
    13.1. Introduction
    13.2. Historical Market Size (US$ Billion) Analysis By Region, 2017 to 2022
    13.3. Current Market Size (US$ Billion) Analysis and Forecast By Region, 2023 to 2033
        13.3.1. North America
        13.3.2. Latin America
        13.3.3. Europe
        13.3.4. South Asia
        13.3.5. East Asia
        13.3.6. Oceania
        13.3.7. Middle East and Africa (MEA)
    13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    14.1. Introduction
    14.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    14.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        14.3.1. By Country
            14.3.1.1. USA
            14.3.1.2. Canada
        14.3.2. By Product
        14.3.3. By Type
        14.3.4. By Dosage Forms
        14.3.5. By Route of Administration
        14.3.6. By Indication
        14.3.7. By Distribution Channel
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Product
        14.4.3. By Type
        14.4.4. By Dosage Forms
        14.4.5. By Route of Administration
        14.4.6. By Indication
        14.4.7. By Distribution Channel
    14.5. Country Level Analysis & Forecast
        14.5.1. USA Market Analysis
            14.5.1.1. Introduction
            14.5.1.2. Market Analysis and Forecast by Market Taxonomy
                14.5.1.2.1. By Product
                14.5.1.2.2. By Type
                14.5.1.2.3. By Dosage Forms
                14.5.1.2.4. By Route of Administration
                14.5.1.2.5. By Indication
                14.5.1.2.6. By Distribution Channel
        14.5.2. Canada Market Analysis
            14.5.2.1. Introduction
            14.5.2.2. Market Analysis and Forecast by Market Taxonomy
                14.5.2.2.1. By Product
                14.5.2.2.2. By Type
                14.5.2.2.3. By Dosage Forms
                14.5.2.2.4. By Route of Administration
                14.5.2.2.5. By Indication
                14.5.2.2.6. By Distribution Channel
    14.6. Market Trends
    14.7. Key Market Participants - Intensity Mapping
    14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    15.1. Introduction
    15.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    15.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        15.3.1. By Country
            15.3.1.1. Brazil
            15.3.1.2. Mexico
            15.3.1.3. Argentina
            15.3.1.4. Rest of Latin America
        15.3.2. By Product
        15.3.3. By Type
        15.3.4. By Dosage Forms
        15.3.5. By Route of Administration
        15.3.6. By Indication
        15.3.7. By Distribution Channel
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Product
        15.4.3. By Type
        15.4.4. By Dosage Forms
        15.4.5. By Route of Administration
        15.4.6. By Indication
        15.4.7. By Distribution Channel
    15.5. Country Level Analysis & Forecast
        15.5.1. Brazil Market Analysis
            15.5.1.1. Introduction
            15.5.1.2. Market Analysis and Forecast by Market Taxonomy
                15.5.1.2.1. By Product
                15.5.1.2.2. By Type
                15.5.1.2.3. By Dosage Forms
                15.5.1.2.4. By Route of Administration
                15.5.1.2.5. By Indication
                15.5.1.2.6. By Distribution Channel
        15.5.2. Mexico Market Analysis
            15.5.2.1. Introduction
            15.5.2.2. Market Analysis and Forecast by Market Taxonomy
                15.5.2.2.1. By Product
                15.5.2.2.2. By Type
                15.5.2.2.3. By Dosage Forms
                15.5.2.2.4. By Route of Administration
                15.5.2.2.5. By Indication
                15.5.2.2.6. By Distribution Channel
        15.5.3. Argentina Market Analysis
            15.5.3.1. Introduction
            15.5.3.2. Market Analysis and Forecast by Market Taxonomy
                15.5.3.2.1. By Product
                15.5.3.2.2. By Type
                15.5.3.2.3. By Dosage Forms
                15.5.3.2.4. By Route of Administration
                15.5.3.2.5. By Indication
                15.5.3.2.6. By Distribution Channel
    15.6. Market Trends
    15.7. Key Market Participants - Intensity Mapping
    15.8. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    16.1. Introduction
    16.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    16.3. Market Size (US$ Billion) Forecast, By Market Taxonomy, 2023 to 2033
        16.3.1. By Country
            16.3.1.1. Germany
            16.3.1.2. France
            16.3.1.3. Italy
            16.3.1.4. UK
            16.3.1.5. Spain
            16.3.1.6. Russia
            16.3.1.7. BENELUX
            16.3.1.8. Nordic Countries
            16.3.1.9. Rest of Europe
        16.3.2. By Product
        16.3.3. By Type
        16.3.4. By Dosage Forms
        16.3.5. By Route of Administration
        16.3.6. By Indication
        16.3.7. By Distribution Channel
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Product
        16.4.3. By Type
        16.4.4. By Dosage Forms
        16.4.5. By Route of Administration
        16.4.6. By Indication
        16.4.7. By Distribution Channel
    16.5. Country Level Analysis & Forecast
        16.5.1. Germany Market Analysis
            16.5.1.1. Introduction
            16.5.1.2. Market Analysis and Forecast by Market Taxonomy
                16.5.1.2.1. By Product
                16.5.1.2.2. By Type
                16.5.1.2.3. By Dosage Forms
                16.5.1.2.4. By Route of Administration
                16.5.1.2.5. By Indication
                16.5.1.2.6. By Distribution Channel
        16.5.2. France Market Analysis
            16.5.2.1. Introduction
            16.5.2.2. Market Analysis and Forecast by Market Taxonomy
                16.5.2.2.1. By Product
                16.5.2.2.2. By Type
                16.5.2.2.3. By Dosage Forms
                16.5.2.2.4. By Route of Administration
                16.5.2.2.5. By Indication
                16.5.2.2.6. By Distribution Channel
        16.5.3. Italy Market Analysis
            16.5.3.1. Introduction
            16.5.3.2. Market Analysis and Forecast by Market Taxonomy
                16.5.3.2.1. By Product
                16.5.3.2.2. By Type
                16.5.3.2.3. By Dosage Forms
                16.5.3.2.4. By Route of Administration
                16.5.3.2.5. By Indication
                16.5.3.2.6. By Distribution Channel
        16.5.4. UK Market Analysis
            16.5.4.1. Introduction
            16.5.4.2. Market Analysis and Forecast by Market Taxonomy
                16.5.4.2.1. By Product
                16.5.4.2.2. By Type
                16.5.4.2.3. By Dosage Forms
                16.5.4.2.4. By Route of Administration
                16.5.4.2.5. By Indication
                16.5.4.2.6. By Distribution Channel
        16.5.5. Spain Market Analysis
            16.5.5.1. Introduction
            16.5.5.2. Market Analysis and Forecast by Market Taxonomy
                16.5.5.2.1. By Product
                16.5.5.2.2. By Type
                16.5.5.2.3. By Dosage Forms
                16.5.5.2.4. By Route of Administration
                16.5.5.2.5. By Indication
                16.5.5.2.6. By Distribution Channel
        16.5.6. Russia Market Analysis
            16.5.6.1. Introduction
            16.5.6.2. Market Analysis and Forecast by Market Taxonomy
                16.5.6.2.1. By Product
                16.5.6.2.2. By Type
                16.5.6.2.3. By Dosage Forms
                16.5.6.2.4. By Route of Administration
                16.5.6.2.5. By Indication
                16.5.6.2.6. By Distribution Channel
        16.5.7. Nordic Countries Market Analysis
            16.5.7.1. Introduction
            16.5.7.2. Market Analysis and Forecast by Market Taxonomy
                16.5.7.2.1. By Product
                16.5.7.2.2. By Type
                16.5.7.2.3. By Dosage Forms
                16.5.7.2.4. By Route of Administration
                16.5.7.2.5. By Indication
                16.5.7.2.6. By Distribution Channel
        16.5.8. BENELUX Market Analysis
            16.5.8.1. Introduction
            16.5.8.2. Market Analysis and Forecast by Market Taxonomy
                16.5.8.2.1. By Product
                16.5.8.2.2. By Type
                16.5.8.2.3. By Dosage Forms
                16.5.8.2.4. By Route of Administration
                16.5.8.2.5. By Indication
                16.5.8.2.6. By Distribution Channel
    16.6. Market Trends
    16.7. Key Market Participants - Intensity Mapping
    16.8. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    17.1. Introduction
    17.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    17.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        17.3.1. By Country
            17.3.1.1. India
            17.3.1.2. Thailand
            17.3.1.3. Indonesia
            17.3.1.4. Malaysia
            17.3.1.5. Rest of South Asia
        17.3.2. By Product
        17.3.3. By Type
        17.3.4. By Dosage Forms
        17.3.5. By Route of Administration
        17.3.6. By Indication
        17.3.7. By Distribution Channel
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Product
        17.4.3. By Type
        17.4.4. By Dosage Forms
        17.4.5. By Route of Administration
        17.4.6. By Indication
        17.4.7. By Distribution Channel
    17.5. Country Level Analysis & Forecast
        17.5.1. India Market Analysis
            17.5.1.1. Introduction
            17.5.1.2. Market Analysis and Forecast by Market Taxonomy
                17.5.1.2.1. By Product
                17.5.1.2.2. By Type
                17.5.1.2.3. By Dosage Forms
                17.5.1.2.4. By Route of Administration
                17.5.1.2.5. By Indication
                17.5.1.2.6. By Distribution Channel
        17.5.2. Thailand Market Analysis
            17.5.2.1. Introduction
            17.5.2.2. Market Analysis and Forecast by Market Taxonomy
                17.5.2.2.1. By Product
                17.5.2.2.2. By Type
                17.5.2.2.3. By Dosage Forms
                17.5.2.2.4. By Route of Administration
                17.5.2.2.5. By Indication
                17.5.2.2.6. By Distribution Channel
        17.5.3. Indonesia Market Analysis
            17.5.3.1. Introduction
            17.5.3.2. Market Analysis and Forecast by Market Taxonomy
                17.5.3.2.1. By Product
                17.5.3.2.2. By Type
                17.5.3.2.3. By Dosage Forms
                17.5.3.2.4. By Route of Administration
                17.5.3.2.5. By Indication
                17.5.3.2.6. By Distribution Channel
        17.5.4. Malaysia Market Analysis
            17.5.4.1. Introduction
            17.5.4.2. Market Analysis and Forecast by Market Taxonomy
                17.5.4.2.1. By Product
                17.5.4.2.2. By Type
                17.5.4.2.3. By Dosage Forms
                17.5.4.2.4. By Route of Administration
                17.5.4.2.5. By Indication
                17.5.4.2.6. By Distribution Channel
    17.6. Market Trends
    17.7. Key Market Participants - Intensity Mapping
    17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    18.1. Introduction
    18.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    18.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        18.3.1. By Country
            18.3.1.1. China
            18.3.1.2. Japan
            18.3.1.3. South Korea
        18.3.2. By Product
        18.3.3. By Type
        18.3.4. By Dosage Forms
        18.3.5. By Route of Administration
        18.3.6. By Indication
        18.3.7. By Distribution Channel
    18.4. Market Attractiveness Analysis
        18.4.1. By Country
        18.4.2. By Product
        18.4.3. By Type
        18.4.4. By Dosage Forms
        18.4.5. By Route of Administration
        18.4.6. By Indication
        18.4.7. By Distribution Channel
    18.5. Country Level Analysis & Forecast
        18.5.1. China Market Analysis
            18.5.1.1. Introduction
            18.5.1.2. Market Analysis and Forecast by Market Taxonomy
                18.5.1.2.1. By Product
                18.5.1.2.2. By Type
                18.5.1.2.3. By Dosage Forms
                18.5.1.2.4. By Route of Administration
                18.5.1.2.5. By Indication
                18.5.1.2.6. By Distribution Channel
        18.5.2. Japan Market Analysis
            18.5.2.1. Introduction
            18.5.2.2. Market Analysis and Forecast by Market Taxonomy
                18.5.2.2.1. By Product
                18.5.2.2.2. By Type
                18.5.2.2.3. By Dosage Forms
                18.5.2.2.4. By Route of Administration
                18.5.2.2.5. By Indication
                18.5.2.2.6. By Distribution Channel
        18.5.3. South Korea Market Analysis
            18.5.3.1. Introduction
            18.5.3.2. Market Analysis and Forecast by Market Taxonomy
                18.5.3.2.1. By Product
                18.5.3.2.2. By Type
                18.5.3.2.3. By Dosage Forms
                18.5.3.2.4. By Route of Administration
                18.5.3.2.5. By Indication
                18.5.3.2.6. By Distribution Channel
    18.6. Market Trends
    18.7. Key Market Participants - Intensity Mapping
    18.8. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    19.1. Introduction
    19.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    19.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        19.3.1. By Country
            19.3.1.1. Australia
            19.3.1.2. New Zealand
        19.3.2. By Product
        19.3.3. By Type
        19.3.4. By Dosage Forms
        19.3.5. By Route of Administration
        19.3.6. By Indication
        19.3.7. By Distribution Channel
    19.4. Market Attractiveness Analysis
        19.4.1. By Country
        19.4.2. By Product
        19.4.3. By Type
        19.4.4. By Dosage Forms
        19.4.5. By Route of Administration
        19.4.6. By Indication
        19.4.7. By Distribution Channel
    19.5. Country Level Analysis & Forecast
        19.5.1. Australia Market Analysis
            19.5.1.1. Introduction
            19.5.1.2. Market Analysis and Forecast by Market Taxonomy
                19.5.1.2.1. By Product
                19.5.1.2.2. By Type
                19.5.1.2.3. By Dosage Forms
                19.5.1.2.4. By Route of Administration
                19.5.1.2.5. By Indication
                19.5.1.2.6. By Distribution Channel
        19.5.2. New Zealand Market Analysis
            19.5.2.1. Introduction
            19.5.2.2. Market Analysis and Forecast by Market Taxonomy
                19.5.2.2.1. By Product
                19.5.2.2.2. By Type
                19.5.2.2.3. By Dosage Forms
                19.5.2.2.4. By Route of Administration
                19.5.2.2.5. By Indication
                19.5.2.2.6. By Distribution Channel
    19.6. Market Trends
    19.7. Key Market Participants - Intensity Mapping
    19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    20.1. Introduction
    20.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    20.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        20.3.1. By Country
            20.3.1.1. GCC Countries
            20.3.1.2. Türkiye
            20.3.1.3. Northern Africa
            20.3.1.4. South Africa
            20.3.1.5. Rest of Middle East and Africa
        20.3.2. By Product
        20.3.3. By Type
        20.3.4. By Dosage Forms
        20.3.5. By Route of Administration
        20.3.6. By Indication
        20.3.7. By Distribution Channel
    20.4. Market Attractiveness Analysis
        20.4.1. By Country
        20.4.2. By Product
        20.4.3. By Type
        20.4.4. By Dosage Forms
        20.4.5. By Route of Administration
        20.4.6. By Indication
        20.4.7. By Distribution Channel
    20.5. Country Level Analysis & Forecast
        20.5.1. GCC Countries Market Analysis
            20.5.1.1. Introduction
            20.5.1.2. Market Analysis and Forecast by Market Taxonomy
                20.5.1.2.1. By Product Type
                20.5.1.2.2. By Route of Administration
                20.5.1.2.3. By Indication
                20.5.1.2.4. By Distribution Channel
        20.5.2. Türkiye Market Analysis
            20.5.2.1. Introduction
            20.5.2.2. Market Analysis and Forecast by Market Taxonomy
                20.5.2.2.1. By Product
                20.5.2.2.2. By Type
                20.5.2.2.3. By Dosage Forms
                20.5.2.2.4. By Route of Administration
                20.5.2.2.5. By Indication
                20.5.2.2.6. By Distribution Channel
        20.5.3. Northern Africa Market Analysis
            20.5.3.1. Introduction
            20.5.3.2. Market Analysis and Forecast by Market Taxonomy
                20.5.3.2.1. By Product
                20.5.3.2.2. By Type
                20.5.3.2.3. By Dosage Forms
                20.5.3.2.4. By Route of Administration
                20.5.3.2.5. By Indication
                20.5.3.2.6. By Distribution Channel
        20.5.4. South Africa Market Analysis
            20.5.4.1. Introduction
            20.5.4.2. Market Analysis and Forecast by Market Taxonomy
                20.5.4.2.1. By Product
                20.5.4.2.2. By Type
                20.5.4.2.3. By Dosage Forms
                20.5.4.2.4. By Route of Administration
                20.5.4.2.5. By Indication
                20.5.4.2.6. By Distribution Channel
    20.6. Market Trends
    20.7. Key Market Participants - Intensity Mapping
    20.8. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
    21.1. Market Analysis by Tier of Companies
    21.2. Market Share Analysis of Top Players
    21.3. Market Presence Analysis
22. Competition Analysis
    22.1. Competition Dashboard
    22.2. Competition Benchmarking
    22.3. Competition Deep Dive
        22.3.1. GlaxoSmithKline PLC.
            22.3.1.1. Overview
            22.3.1.2. Product Portfolio
            22.3.1.3. Profitability by Market Segments (Product/Region)
            22.3.1.4. Sales Footprint
            22.3.1.5. Strategy Overview
        22.3.2. Sanofi Consumer Healthcare
        22.3.3. Himalaya Wellness Company
        22.3.4. Sun Pharmaceutical Industries, Inc.
        22.3.5. Bayer AG
        22.3.6. Novartis AG
        22.3.7. Cadila Pharmaceuticals
        22.3.8. Bausch Health Companies Inc.
        22.3.9. Alcon Vision LLC.
        22.3.10. Merck & Co.
        22.3.11. Dr. Reddy’s Laboratories, Ltd.
        22.3.12. Viatris Inc.
        22.3.13. Somerset Pharma, LLC
        22.3.14. F. Hoffmann- La Roche Ltd.
        22.3.15. Akorn Operating Company LLC
        22.3.16. Teva Pharmaceutical Industries Ltd.
        22.3.17. Speer laboratories
        22.3.18. Glenmark Pharmaceuticals Limited
        22.3.19. TerSera Therapeutics LLC
        22.3.20. Pfizer Inc.
        22.3.21. Johnson & Johnson Consumer Inc.
        22.3.22. Pharmaceutical Specialties Inc.
        22.3.23. Proctor & Gamble
23. Assumptions and Acronyms Used
24. Research Methodology
Recommendations

Healthcare

Nasal Antihistamines Market

June 2023

REP-GB-13708

315 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Antihistamine Market

Schedule a Call